National Priority Voucher Program
The FDA announced the first nine companies to participate in its National Priority Voucher program, which aims to promote novel treatments that benefit the health interests of Americans.
Nine medications are on the initial list of program participants, including those that meet a large, unmet need or reduce downstream health care utilization, as well as medications that utilize MFN pricing.
The Priority Voucher program is a new initiative at the agency to promote novel treatments that FDA believes will benefit the health interests of Americans.
Author's summary: FDA announces participants in National Priority Voucher program.
- Nine medications are part of the initial list
- Program aims to promote novel treatments
- Medications must meet a large, unmet need or reduce health care utilization
More News
- Brewers Go Out With a Whimper in NLCS
- Platforms of Extremism: Why Australia Must Confront Digital Misogyny as a Security Threat - Australian Institute of International Affairs
- Bombers win ugly to keep playoff hopes alive
- SoCal freeway shut down for miles due to event involving live ammunition at Camp Pendleton
- TBA, Appraisal, Reverse Mortgage Tools; STRATMOR on AI and Competition; Can the CFPB be Willed Away?
- 'No Kings' protests against Trump planned nationwide, in what the GOP calls 'hate America' rallies
- Manchester United’s stance on Kobbie Mainoo leaving Old Trafford in January revealed
- ‘No Kings’ protests liveblog: Scenes from around Southern Colorado’s big and small cities and towns
- Borrower Monitoring, AI Processing, DPA, Verification Tools; Events and Training; Robots Will do What?
- “Highly rated” Man Utd youngster could be the solution for Rúben Amorim’s biggest problem